TNF and type 2 diabetes mellitus: Furthermore, some well-known pathogenic pro-inflammatory mediators in RA, such as interleukin-1β (IL-1β) and tumor necrosis factor (TNF), may play a pivotal role in the development of T2D, contributing to beta-cells disfunction and distruction and insulin resistance as observed in bone damage [13,14].